Cargando…

Thresholds of iron markers for iron deficiency erythropoiesis—finding of the Japanese nationwide dialysis registry

Reportedly, serum ferritin levels are much lower in Japanese hemodialysis (HD) patients than their Western counterparts. Therefore, the cutoff values of ferritin and transferrin saturation (TSAT) for iron deficiency might differ from other countries. We conducted a cross-sectional observational stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamano, Takayuki, Fujii, Naohiko, Hayashi, Terumasa, Yamamoto, Hiroyasu, Iseki, Kunitoshi, Tsubakihara, Yoshiharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455189/ https://www.ncbi.nlm.nih.gov/pubmed/26097782 http://dx.doi.org/10.1038/kisup.2015.6

Ejemplares similares

The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry
por: Maruyama, Yukio, et al.
Publicado: (2015)

Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population
por: Hanafusa, Norio, et al.
Publicado: (2015)

Magnesium Modifies the Cardiovascular Mortality Risk Associated with Hyperphosphatemia in Patients Undergoing Hemodialysis: A Cohort Study
por: Sakaguchi, Yusuke, et al.
Publicado: (2014)

Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry
por: Yazawa, Masahiko, et al.
Publicado: (2016)

Correction: Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry
por: Yazawa, Masahiko, et al.
Publicado: (2016)

Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching
por: Obi, Yoshitsugu, et al.
Publicado: (2017)

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
por: Narita, Ichiei, et al.
Publicado: (2022)

Sharing knowledge on dialysis registries worldwide
por: Iseki, Kunitoshi, et al.
Publicado: (2015)

Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study
por: Tagawa, Miho, et al.
Publicado: (2014)

Iron Mining for Erythropoiesis
por: Correnti, Margherita, et al.
Publicado: (2022)

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
por: Hasegawa, Takeshi, et al.
Publicado: (2023)

Erythropoiesis and iron metabolism in Hodgkin's disease.
por: Al-Ismail, S., et al.
Publicado: (1979)

Erythropoiesis and Iron Sulfur Cluster Biogenesis
por: Ye, Hong, et al.
Publicado: (2010)

Crosstalk between Erythropoiesis and Iron Metabolism
por: Rivella, Stefano, et al.
Publicado: (2010)

Crosstalk between Iron Metabolism and Erythropoiesis
por: Li, Huihui, et al.
Publicado: (2010)

Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry
por: Abe, Masanori, et al.
Publicado: (2017)

Iron Loading and Overloading due to Ineffective Erythropoiesis
por: Tanno, Toshihiko, et al.
Publicado: (2010)

The relationship between systemic iron homeostasis and erythropoiesis
por: Rishi, Gautam, et al.
Publicado: (2017)

Imbalance of erythropoiesis and iron metabolism in patients with thalassemia
por: Huang, Yumei, et al.
Publicado: (2019)

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia
por: Li, Yihang, et al.
Publicado: (2022)

Biomarkers of Hypochromia: The Contemporary Assessment of Iron Status and Erythropoiesis
por: Urrechaga, Eloísa, et al.
Publicado: (2013)

A biomathematical model of human erythropoiesis and iron metabolism
por: Schirm, Sibylle, et al.
Publicado: (2020)

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis
por: Ginzburg, Yelena, et al.
Publicado: (2023)

Effect of stimulated erythropoiesis on liver SMAD signaling pathway in iron-overloaded and iron-deficient mice
por: Frýdlová, Jana, et al.
Publicado: (2019)

Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients
por: Sakao, Yukitoshi, et al.
Publicado: (2016)

β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)

Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice
por: Settakorn, Kornvipa, et al.
Publicado: (2022)

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
por: Kato, Hideki, et al.
Publicado: (2017)

Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status
por: Toblli, Jorge Eduardo, et al.
Publicado: (2015)

Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
por: Khalil, Shadi, et al.
Publicado: (2018)

Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
por: Mirciov, Cornel S.G., et al.
Publicado: (2018)

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
por: Ganz, Tomas, et al.
Publicado: (2023)

Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron
por: Silverberg, Donald S, et al.
Publicado: (2014)

Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive
por: Susanah, Susi, et al.
Publicado: (2021)

Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012
por: Iseki, Kunitoshi
Publicado: (2013)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2016)

Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: The Kyushu Dialysis-Related Amyloidosis Study
por: Tsuruya, Kazuhiko, et al.
Publicado: (2021)

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients
por: Koike, Kiyomi, et al.
Publicado: (2016)

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
por: Huang, Yumei, et al.
Publicado: (2019)

Iron status and erythropoiesis response to darbepoetin alfa in dogs with chronic kidney disease
por: BHAMARASUTA, Chayanont, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_caujvfq8u680qm24c9b9b5iol9